Research Reports Initiated on Healthcare Stocks Centric Health, TSO3, Lattice Biologics, and Emerald Health Therapeutics

LONDON, UK / ACCESSWIRE / November 30, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare sector. Companies recently under review include Centric Health, TSO3, Lattice Biologics, and Emerald Health Therapeutics. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

On Tuesday, November 29, 2016, the Toronto Exchange Composite Index was down 0.10%, finishing the day at 14,999.81. The TSX Venture Composite Index, on the other hand, closed at 734.91, down 0.26%.

The Healthcare Index was in the black, closing the day at 73.48, up 2.65%.

Active Wall St. has initiated research reports on the following equities: Centric Health Corporation (TSX: CHH), TSO3 Inc. (TSX: TOS), Lattice Biologics Ltd (TSX-V: LBL), and Emerald Health Therapeutics Inc. (TSX-V: EMH). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Centric Health Corp.

Toronto, Canada headquartered Centric Health Corp.’s stock fell 1.01%, to close the day at $0.49. The stock recorded a trading volume of 85,583 shares. Centric Health’s shares have gained 16.67% in the last one month and 25.64% in the past three months. Furthermore, the stock has surged 63.33% in the previous one year. The company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $0.41 is greater than its 200-day moving average of $0.32. Shares of the Company, which provides healthcare services to its patients and customers in Canada, are trading at a PE ratio of 1.52. See our research report on CHH.TO at: http://www.activewallst.com/registration-3/?symbol=CHH.

TSO3 Inc.

On Tuesday, shares in Quebec, Canada headquartered TSO3 Inc. recorded a trading volume of 169,190 shares. The stock ended the day 0.77% lower at $2.57. TSO3’s stock has gained 26.60% in the past one year. Shares of the Company, which engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat-sensitive medical devices in Canada and internationally, are trading below its 50-day and 200-day moving averages. The company stock’s 50-day moving average of $3.00 is above its 200-day moving average of $2.98. The complimentary research report on TOS.TO at: http://www.activewallst.com/registration-3/?symbol=TOS.

Lattice Biologics Ltd.

On Tuesday, shares in Scottsdale, Arizona headquartered Lattice Biologics Ltd. ended the session 11.11% lower at $0.20 with a total volume of 2,000 shares traded. Lattice Biologics’ shares have rallied 122.22% in the past one year. Shares of the company, which provides personalized/precision medicine for cellular therapies and tissue engineering, are trading below its 50-day and 200-day moving averages. Further, the stock’s 50-day moving average of $0.24 is greater than its 200-day moving average of $0.22. Register for free and access the latest research report on LBL.V at: http://www.activewallst.com/registration-3/?symbol=LBL.

Emerald Health Therapeutics Inc.

Victoria, Canada headquartered Emerald Health Therapeutics Inc.’s stock gained 7.41%, to finish Tuesday’s session at $1.45 with a total volume of 652,972 shares traded. Over the last one month and the previous three months, Emerald Health Therapeutics’ shares have surged 70.59% and 281.58%, respectively. Furthermore, the stock has rallied 297.26% in the past one year. Shares of the Company, which together with its subsidiaries, produces and sells medical marijuana in Canada, are trading above its 50-day and 200-day moving averages. Emerald Health Therapeutics’ 50-day moving average of $0.98 is above its 200-day moving average of $0.49. Get free access to your research report on EMH.V at: http://www.activewallst.com/registration-3/?symbol=EMH.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 450009